Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 1.150
-0.050 (-4.17%)
Aug 12, 2026, 8:01 AM CET
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €1.01 million as of August 12, 2026. Its market cap has increased by 30.69% in one year.
Market Cap
1.01M
Enterprise Value
11.98M
Revenue
24.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.15
ChartMarket Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 1.01M, a decrease of -98.06%. That is a compound annual growth rate of -28.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 1.01M | 27.78% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.39B |
| Bayer Aktiengesellschaft | 48.09B |
| Siemens Healthineers AG | 44.07B |
| Fresenius SE & Co. KGaA | 26.56B |
| aap Implantate AG | 21.98M |
| Maternus-Kliniken Aktiengesellschaft | 19.71M |
| Biofrontera AG | 15.44M |
| Geratherm Medical AG | 14.02M |